Navigation Links
Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation
Date:2/26/2009

- Expands Beckman Coulter's Worldwide Position in Clinical Chemistry

- Complementary Market Positions and Product Portfolios in Chemistry and Automation Broaden Global Opportunity, Increase Customer Choice

- Penetration of Beckman Coulter's Immunoassay Products into Olympus' Installed Chemistry Base Supports Continued Above-Market Growth

- Transaction Expected to be Accretive to Non-GAAP Earnings Per Share in 2010

ORANGE COUNTY, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, and Olympus Corporation, a Tokyo-headquartered precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, announced today that they have entered into a definitive agreement under which Beckman Coulter will acquire the diagnostic systems portion of Olympus' Life Sciences business for 77.45 billion yen, or approximately USD $800 million.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

This acquisition will broaden Beckman Coulter's Chemistry offering, establishing a leadership position with particular strength in larger hospital laboratories. In addition, the transaction will extend our broad chemistry customer base representing a valuable new customer set for Beckman Coulter's Immunoassay products.

In 2010, the Olympus Diagnostics business is anticipated to increase Beckman Coulter's revenue by approximately $500 million on a full year basis and generate approximately $40 to $50 million in operating income (excluding FAS141R associated amortization). Beckma
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
2. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
3. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
4. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
5. Beckman Coulter to Host Annual Business Review
6. Beckman Coulter to Present at Upcoming Healthcare Conferences
7. Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
8. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
9. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
10. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
11. Beckman Coulter Investor Events Second Half of 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... -- Research and Markets has announced ... Report 2014" report to their offering. ... is a professional and in-depth study on the ... The report provides a basic overview of ... chain structure. The N-acetylcysteine market analysis is provided ...
(Date:9/18/2014)... -- U.S. biotech company Kultevat has strengthened its ... developed by the Donald Danforth Plant Science Center ... applications in production of natural rubber in Taraxicum ... under the direction of Roger Beachy , Ph.D., ... the Danforth Plant Science Center, and is used to ...
(Date:9/18/2014)... , Pennsylvanie, 18 septembre 2014 ... en 1974, a été depuis 40 ... les évaluations cliniques traditionnelles par des évaluations ... et sur les impacts économiques des traitements. ... A cours d,une récente ...
(Date:9/18/2014)... a group of rare diseases that afflict skeletal ... onset hits at the fetal stage and is ... gene encoding fibroblast growth factor receptor 3 (FGFR3) ... dysplasia, thanatophoric dysplasia (TD), a skeletal dysplasia that ... often lethal, and achondroplasia (ACH), which causes stunted ...
Breaking Biology Technology:Global N-acetylcysteine Industry Report 2014 2Kultevat obtains license of gene switch technology 21974 - 2014 - Mapi fĂȘte ses 40 ans 2Researchers use iPS cells to show statin effects on diseased bone 2Researchers use iPS cells to show statin effects on diseased bone 3
... Corporation , (HLC) headquartered in Milwaukee, the world's largest ... leading music education technology company, announced today that will ... music students: Essential Elements 2000 for Band Book 1 ... , ,SmartMusic is technology-based music practice system with over ...
... teachers can now better organize and plan their teaching by ... is part of their instructional process due to the release ... Additionally the new software allows all other medical disciplines to ... creates a patients instructions, the systems Visit Summary Tree lists ...
... Journal featured the news of pharmaceutical giant Pfizer ... $1.3 billion. , ,Esperion, which is based in ... useful for the treatment of the heart disease atherosclerosis. ... drugs like Lipitor for high cholesterol ($8 billion in ...
Cached Biology Technology:Logicare Improves Patient Education Systems Technology 2Holiday Gift From Big Pharma 2
(Date:9/18/2014)... 18, 2014Many Americans across racial and ethnic groups ... impact on their day-to-day life, more so than ... and speech (57% of African-Americans, 49% of non-Hispanic ... When asked which disease or ailment is the ... first among African-Americans followed by AIDS/HIV. Hispanics ...
(Date:9/18/2014)... 18, 2014 Elsevier, a world-leading provider of ... and the Australasian Research Management Society (ARMS), recognized ... at the 5th Scopus Young Researcher of the ... today at the National Convention Centre and in ... attended by guests representing Australia,s and New Zealand,s ...
(Date:9/18/2014)... lives nestling in the protective tentacles of host anemones, ... travel hundreds of kilometres across the open ocean. Although ... been predicted, this is the first time that the ... been observed. , Dr Steve Simpson, Senior Lecturer in ... Exeter, and colleagues from the Australian Research Council Centre ...
Breaking Biology News(10 mins):Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Expedition finds Nemo can travel great distances to connect populations 2Expedition finds Nemo can travel great distances to connect populations 3
... 31, 2008 - Biofuels are widely considered one of ... makers and environmentalists alike. However, unless principles and standards ... cause severe environmental impacts and reduce biodiversity the ... is currently the most widely used biofuel in the ...
... Leading academics and practitioners from the northeast United ... and nanotechnology such as the printing of human ... for relieving lower back pain at a conference ... is the first time that Brown has hosted the ...
... used by the medical profession, chloroform, has shed light on ... how such anaesthetics actually work. A discovery described ... Yahya Bahnasi, has provided a clue that may unravel the ... design new generations of anaesthetics without harmful side effects. ...
Cached Biology News:Study finds concerns with biofuels 2Brown hosts regional bioengineering conference 2Chloroform provides clue to 150 year old medical puzzle 2
Amino Acid Analysis is performed using ion-exchange separation of the amino acids from acid hydrolysates, followed by ninhydrin detection. Typical quantities required are 0.1 to 0.5 mg, depending on...
ANTI CORTIS BIN GLOB...
ANTI S. ENTERID LPS...
... ELISA Development kit contains the basic components ... to measure natural and recombinant rat L-Selectin ... Each kit contains sufficient materials to run ... that the following conditions are met: ...
Biology Products: